NCT06121401
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06121401
Title First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients (IOLANTHE)
Acronym IOLANTHE
Recruitment Active, not recruiting
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Mario Negri Institute for Pharmacological Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia Como 22042 Italy Details
Spedali Civili Brescia Italy Details
Policlinico Careggi Florence Italy Details
Ospedale Manzoni Lecco Italy Details
Ospedale San Luca Lucca Italy Details
Istituto Europeo di Oncologia Milan Italy Details
Istituto Nazionale dei Tumori Milan Italy Details
Istituto Oncologico Veneto IRCCS Padova 35128 Italy Details
AOU Parma Parma Italy Details
Ospedale Santa Chiara Pisa Italy Details
Arcispedale Santa Maria Nuova Reggio Emilia Italy Details
Ospedale Umberto I Roma Italy Details
A.O. Ordine Mauriziano Torino Italy Details
A.O.U. Citta della Salute e della Scienza Torino Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field